CLSA thinks pharma sector fundamentals are stronger now than in 2015. A stable U.S. generics market, a strong outlook for India businesses, much ...
Read more: CLSA Maintains Buy Rating on Sun Pharma, Cadila Healthcare, Torrent Pharma and Abbott India ...